The effect of long-term thyroxine on bone mineral density and serum cholesterol

Journal of the Royal College of Physicians of London

Volumn 30, Issue 6, 1996, Pages 527-532

  Fowler, P B S ^a,c   McIvor, J ^a   Sykes, L ^b   Macrae, K D ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b Shirley Holms ^*  (United Kingdom)

^c Shirley Holms   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; THYROTROPIN; THYROXINE;

ARTICLE; BLOOD; BONE DENSITY; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; FEMALE; FEMUR NECK; HUMAN; HYPOTHYROIDISM; LUMBAR VERTEBRA; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; OSTEOPOROSIS; PATHOLOGIC FRACTURE; PATHOPHYSIOLOGY; THYROTOXICOSIS;

BONE DENSITY; CASE-CONTROL STUDIES; CHOLESTEROL; CORONARY DISEASE; FEMALE; FEMUR NECK; FRACTURES, SPONTANEOUS; HUMANS; HYPOTHYROIDISM; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS; STATISTICS, NONPARAMETRIC; THYROTOXICOSIS; THYROTROPIN; THYROXINE;

EID: 0030277060     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ross DS, Neer RM, Ridgway EC, Daniels DH. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med 1987;82:1176.
2. Krolner B, Vesterdal Jorgensen J, Pors Nielsen S. Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and antithyroid treatment. Clin Endocrinol 1983;18:439-46.
3. Stall GM, Harris S, Sokoll IJ, Dawson-Hughes B. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med 1990;113:265-9.
4. Terri LP, Kerrigan J, Kelly AM, Braverman LE, Baran DT. Long-term L-thyroxine therapy is associated with decreased hip bone density in pre-menopausal women. JAMA 1988;259:3137-41.
5. Harvey R, McHardy K, Robins S, Taylor G, et al. Bone collagen degradation in thyrotoxicosis and thyroid replacement therapy measured by urinary pyridinolene and deoxypyridinolene excretion. Ann Endocrinol (Paris) 1989;50:122.
6. Franklyn JA, Betteridge J, Daykin J, Holder R, et al. Long-term thyroxine treatment and bone mineral density. Lancet 1992;340:9-13.
7. Florkowski CM, Browne BEW, Elliot JR, Ayling EN, Turner JG. Bone mineral density in patients receiving snppressive doses of thyroxine for thyroid carcinoma. N Z Med J 1993;106:443-4.
8. Kung AWC, Lorentz T, Tam SCF. Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women. Clin Endocrinol 1993;39:535-40.
9. Faber J, Galloe AM. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 1994;130:350-6.
10. Fowler PBS, Swale J, Andrew H. Hypercholesterolaemia in borderline hypothyroidism. Lancet 1970;ii:488-9.
11. Lewis B. Premyxoedema: entity or non-entity? Proc Roy Soc Med 1977;70:583.
12. Ball MJ, Griffiths D, Thorogood M. Asymptomatic hypothyroidism and hypercholesterolaemia. J Roy Soc Med 1991;84:527-9.
13. Tieche M, Lupi GA, Gutzwiller F, Grob PJ, et al. Borderline low thyroid function and thyroid autoimmunity. Risk factors for coronary heart disease? Br Heart J 1981;46:202-6.
14. Dean JW, Fowler PBS. Peer review at work. Exaggerated responsiveness to thyrotrophin releasing hormone: a risk factor in women with coronary artery disease. Br Med J 1985;290:1555-61.
15. Bastenie PA, Vanhaelst L, Goldstein J, Smets PH, et al. Asymptomatic autoimmune thyroiditis and coronary artery disease. Cross-sectional and prospective studies. Lancet 1977;ii:155-8.
16. Elder J, McLelland A, O'Reilly DS, Packard CJ, et al. The relationship between serum cholesterol and serum thyrotrophin, thyroxine and triiodothyronine concentrations in suspected hypothyroidism. Ann Clin Biochem 1990;27:110-3.
17. Caron P, Calazel G, Parra HJ, Hoff M, et al. Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy. Clin Endocrinol 1990;35:519-23.
18. Stubbs PJ, Mulrooney BD, Gollinson PO, Fowler PBS, Noble MIM. Serum lipids and thyrotrophin in women with coronary artery disease. Eur Heart J 1994;15:468-71.
19. Powell J, Alaghband-Zadeh J, Carter G, Greenhalgh RM, Fowler PBS. Raised serum thyrotrophin in women with peripheral arterial disease. Br J Surg 1987;74:1139-41.
20. Franklyn JA, Daykin J, Betteridge J, Hughes EA, et al. Thyroxine replacement therapy and circulating lipid concentrations. Clin Endocrinol 1993;38:453-9.
21. Miura S, Litaka M, Yoshimura H, Kitahama S, et al. Disturbed lipid metabolism in patients with sub-clinical hypothyroidism: effects of L-thyroxine therapy. Intern Med 1994;33:413-7.